Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is 3.93 as of 2026-10-06T15:56:30.726Z.
Calculation as of: 2026-10-06T15:56:30.726Z.
Quote observation: 2026-10-06T15:55:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
3.93
SECTOR MEDIAN · HEALTHCARE
2.39
median of 624 covered companies
CURRENT VS SECTOR MEDIAN
+64.44%
vs the sector median at left
Market Cap
$1.86B
PB Ratio
8.57
TTM Avg
21.47
3Y Avg
13.30
5Y Avg
13.30
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.79B | 3.93 | N/A | N/A | N/A |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 4.33 | 5.58 | 5.58 | 5.07 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 6.58 | 20.53 | 18.19 | 13.71 |
| Novocure Ltd (NVCR)vs › | $1.84B | 5.43 | 4.80 | 5.01 | 9.97 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | 2.38 | 2.19 | 1.95 | 3.16 |
| Absci Corporation (ABSI)vs › | $1.84B | 7.47 | 4.16 | 2.63 | 2.00 |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 2.21 | 1.97 | 2.43 | 2.72 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 1.27 | 1.63 | 1.68 | 1.82 |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.86B | 8.57 | 21.47 | 13.30 | 13.30 |
| Personalis, Inc. (PSNL)vs › | $1.70B | 7.24 | 4.56 | 2.49 | 1.84 |
P/B Ratio
3.93
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
